Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer
Together with fibroblast growth factors (FGFs) 19 and 21, FGF23 is an endocrine member of the family of FGFs. Mainly secreted by bone cells, FGF23 acts as a hormone on the kidney, stimulating phosphate excretion and suppressing formation of 1,25(OH)2D3, active vitamin D. These effects are dependent...
Main Authors: | Franz Ewendt, Martina Feger, Michael Föller |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2020.601006/full |
Similar Items
-
The impact of SGLT2 inhibitors on αKlotho in renal MDCK and HK-2 cells
by: Lisa Wolf, et al.
Published: (2023-03-01) -
Tachysterol2 increases the synthesis of fibroblast growth factor 23 in bone cells
by: Franz Ewendt, et al.
Published: (2022-07-01) -
Oncostatin M is a regulator of fibroblast growth factor 23 (FGF23) in UMR106 osteoblast-like cells
by: Sina Münz, et al.
Published: (2023-05-01) -
PKC regulates the production of fibroblast growth factor 23 (FGF23).
by: Ludmilla Bär, et al.
Published: (2019-01-01) -
FGF23 Actions on Target Tissues—With and Without Klotho
by: Beatrice Richter, et al.
Published: (2018-05-01)